Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/61011
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Estella-Hermoso de Mendoza, A. | - |
dc.contributor.author | Campanero, Miguel A. | - |
dc.contributor.author | Mollinedo, Faustino | - |
dc.contributor.author | Blanco-Prieto, María J. | - |
dc.date.accessioned | 2012-11-23T12:52:04Z | - |
dc.date.available | 2012-11-23T12:52:04Z | - |
dc.date.issued | 2009 | - |
dc.identifier | doi: 10.1166/jbn.2009.1042 | - |
dc.identifier | issn: 1550-7033 | - |
dc.identifier | e-issn: 1550-7041 | - |
dc.identifier.citation | Journal of Biomedical Nanotechnology 5(4): 323-343 (2009) | - |
dc.identifier.uri | http://hdl.handle.net/10261/61011 | - |
dc.description.abstract | More than half of all people diagnosed with cancer receive chemotherapy. Unfortunately, most chemotherapy drugs cannot tell the difference between a cancer cell and a healthy cell. In this sense, some other drawbacks often encountered with antineoplastic compounds, such as poor stability and specificity and a high occurrence of drug-resistant tumor cells may be overcome to some degree by incorporating them into drug delivery systems. Solid Lipid Nanoparticles (SLN) have arisen considerable interest in recent years. These are particles of submicron size made from a lipid matrix that is solid at room and body temperature. Moreover, the biodegradable and biocompatible nature of SLN makes them less toxic than other nanoparticulate systems. SLN are capable of encapsulating hydrophobic and hydrophilic drugs, and they also provide protection against chemical, photochemical or oxidative degradation of drugs, as well as the possibility of a sustained release of the incorporated drugs. Along with these last issues, the feasibility of scaling up for large scale production and the low cost of lipids as compared to biodegradable polymers or phospholipids have favoured their use as potential drug delivery systems. This review focuses on the recent advances in SLN as carriers for chemotherapeutic agent delivery. | - |
dc.language.iso | eng | - |
dc.publisher | American Scientific Publishers | - |
dc.rights | closedAccess | - |
dc.title | Lipid nanomedicines for anticancer drug therapy | - |
dc.type | artículo | - |
dc.identifier.doi | 10.1166/jbn.2009.1042 | - |
dc.date.updated | 2012-11-23T12:52:05Z | - |
dc.description.version | Peer Reviewed | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | artículo | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
80
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
71
checked on 23-feb-2024
Page view(s)
349
checked on 26-abr-2024
Download(s)
127
checked on 26-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.